Opportunity Information: Apply for RFI 695 19 OVC 00001
USAID/Burundi published a Request for Information (RFI) titled "USAID/Burundi Orphans and Vulnerable Children (OVC) Local Activity" (RFI 695 19 OVC 00001) to gather input from interested parties to help shape the design of a future health-focused activity in Burundi. This is not a notice of an immediate grant award by itself, but rather an information-gathering step USAID uses to understand what approaches, capacities, partnerships, and implementation considerations exist before releasing a formal solicitation.
The planned activity centers on orphans and vulnerable children (OVC) and is designed to reduce and mitigate HIV risk among these children, improve identification of HIV-positive OVC through strengthened case-finding, and reinforce linkages between community-level support and clinical HIV services. A key emphasis is preventing sexual violence and promoting HIV risk-reduction, reflecting the heightened vulnerability many children face due to trauma, exploitation, unsafe living conditions, and limited access to protective services. The activity would be implemented in targeted provinces, although the RFI summary does not list specific provinces.
A defining feature of the opportunity is USAID/Burundi's intent to channel any resulting award to a local Burundian organization. The stated purpose of this local implementation approach is to build long-term sustainability in Burundi's efforts to control the HIV epidemic by strengthening domestic leadership, institutional capacity, and locally rooted service delivery systems. Eligibility is broadly framed as "all interested parties" for purposes of responding to the RFI, meaning organizations and stakeholders are invited to submit information, perspectives, and recommendations that can inform the final program design.
In the source listing, the opportunity is categorized under discretionary funding and the health sector (CFDA 98.001), with the funding instrument type listed as "Other." The posting shows an award ceiling of 0 and no expected awards, which is consistent with an RFI stage where USAID is not yet committing funding or announcing a competitive award, but instead preparing for a later solicitation. The notice was created on March 12, 2019, with an original closing date of March 29, 2019. The agency information references USAID in the region (notably "Rwanda USAID-Kigali" in the source data), while the activity description clearly places the program focus with USAID's office in Bujumbura, Burundi.Apply for RFI 695 19 OVC 00001
- The Rwanda USAID-Kigali in the health sector is offering a public funding opportunity titled "USAID/Burundi Orphans and Vulnerable Children (OVC) Local Activity" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on 2019-03-12.
- Applicants must submit their applications by 2019-03-29. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
1) What is this opportunity?
This is a USAID/Burundi Request for Information (RFI) titled "USAID/Burundi Orphans and Vulnerable Children (OVC) Local Activity" (RFI 695 19 OVC 00001). An RFI is an information-gathering notice used to collect input from interested parties before USAID decides on a final activity design and releases any formal solicitation.
2) Is this RFI a grant competition or an announcement of funding?
No. The RFI is not a notice of an immediate grant award and does not, by itself, represent a funding opportunity that will result in an award. It is a step USAID uses to understand available approaches, capacities, partnerships, and implementation considerations prior to issuing a formal solicitation.
3) What is USAID trying to learn by issuing this RFI?
USAID is seeking information and perspectives to help shape the design of a future health-focused activity in Burundi. The RFI is intended to inform what program approaches could work, what local capacities exist, what partnerships may be needed, and what practical implementation considerations should be addressed before a formal solicitation is released.
4) What population is the planned activity focused on?
The planned activity centers on orphans and vulnerable children (OVC) in Burundi.
5) What are the main objectives of the planned activity?
Based on the RFI summary, the activity is designed to: reduce and mitigate HIV risk among orphans and vulnerable children; improve identification of HIV-positive OVC through strengthened case-finding; and reinforce linkages between community-level support and clinical HIV services.
6) What does "strengthened case-finding" mean in this context?
In the context of the RFI summary, strengthened case-finding refers to improving the identification of HIV-positive orphans and vulnerable children, so that children who are HIV-positive can be detected and connected to appropriate clinical services and support.
7) How does the activity connect community support with clinical HIV services?
The RFI indicates a focus on reinforcing linkages between community-level support and clinical HIV services. This implies an intentional connection between services delivered in the community (such as support and protective services for children) and formal health facilities providing HIV-related clinical care.
8) Why does the planned activity emphasize prevention of sexual violence?
The RFI highlights preventing sexual violence and promoting HIV risk-reduction because many children face heightened vulnerability due to trauma, exploitation, unsafe living conditions, and limited access to protective services. These conditions can increase risk of HIV exposure and other harms, making prevention and protective measures a key emphasis.
9) Where in Burundi would the activity be implemented?
The RFI summary states the activity would be implemented in targeted provinces, but it does not list which provinces in the provided information.
10) Who is intended to implement the activity if a future award is made?
A defining feature described in the RFI summary is USAID/Burundi's intent to channel any resulting award to a local Burundian organization. This reflects an emphasis on local implementation.
11) Why is USAID emphasizing local implementation by a Burundian organization?
The stated purpose is to build long-term sustainability in Burundi's efforts to control the HIV epidemic by strengthening domestic leadership, institutional capacity, and locally rooted service delivery systems.
12) Who can respond to this RFI?
Eligibility is described broadly as "all interested parties" for purposes of responding to the RFI. This means organizations and stakeholders are invited to submit information, perspectives, and recommendations to inform the final program design.
13) Does responding to the RFI mean an organization will receive an award later?
No. The provided information describes the RFI as a way to gather input and does not indicate that submitting information guarantees eligibility for, preference in, or receipt of a future award.
14) What sector and assistance category is this associated with?
In the source listing, the opportunity is categorized under discretionary funding and the health sector, with CFDA 98.001.
15) What is the funding instrument type for this notice?
The funding instrument type is listed as "Other" in the source listing, which aligns with the fact that this is an RFI rather than a standard grant award notice.
16) Why does the posting show an award ceiling of 0 and no expected awards?
This is consistent with an RFI stage where USAID is not committing funding or announcing a competitive award. The RFI is preparatory and intended to inform a later solicitation.
17) What are the key dates mentioned for this RFI?
The notice was created on March 12, 2019, and the original closing date listed is March 29, 2019.
18) Which USAID office is associated with this notice?
The activity description places the program focus with USAID's office in Bujumbura, Burundi. The agency information in the source data references USAID in the region (including "Rwanda USAID-Kigali").
19) Is there a formal solicitation available now?
Not based on the provided information. The notice described is an RFI intended to shape the design of a future activity before USAID releases a formal solicitation.
20) What should interested parties submit in response to the RFI?
The provided information indicates USAID is seeking input that can inform activity design, including recommendations and information on approaches, capacities, partnerships, and implementation considerations. Specific submission instructions are not included in the provided summary.
Browse more opportunities from the same category: Health
Next opportunity: Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)
Previous opportunity: Research and Development for Genome Reference Representations (GRR) (U01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFI 695 19 OVC 00001
Applicants also applied for:
Applicants who have applied for this opportunity (RFI 695 19 OVC 00001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34) Apply for PAR 19 218 Funding Number: PAR 19 218 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing Access to Research Careers (T34) Apply for PAR 19 219 Funding Number: PAR 19 219 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed) Apply for PAR 19 220 Funding Number: PAR 19 220 Agency: National Institutes of Health Category: Health Funding Amount: $650,000 |
| Notice of Stakeholders Meeting on USAID/PEPFAR Strategic Plan for Strengthening Indigenous Partnerships Apply for 720611 PEPFAR HEALTH PARTNERS MEETING Funding Number: 720611 PEPFAR HEALTH PARTNERS MEETING Agency: Zambia USAID-Lusaka Category: Health Funding Amount: Case Dependent |
| U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (U01 Clinical Trial Optional) Apply for RFA AI 19 025 Funding Number: RFA AI 19 025 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (R01 Clinical Trial Optional) Apply for RFA AI 19 024 Funding Number: RFA AI 19 024 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Atopic Dermatitis Research Network -Clinical Research Centers (U01 Clinical Trial Optional) Apply for RFA AI 19 015 Funding Number: RFA AI 19 015 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Institutional Translational Research Training Program (T32) Apply for PAR 19 228 Funding Number: PAR 19 228 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Health Services Research Project: Partners Enabling Diagnostic Excellence (R01) Apply for RFA HS 19 003 Funding Number: RFA HS 19 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Informatics Methodology and Secondary Analyses for Immunology Data in ImmPort (UH2 Clinical Trial Not Allowed) Apply for PAR 19 229 Funding Number: PAR 19 229 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Preventive Health and Health Services Block Grant– 2019 Apply for CDC RFA OT19 1902 Funding Number: CDC RFA OT19 1902 Agency: Centers for Disease Control - OSTLTS Category: Health Funding Amount: Case Dependent |
| Development of Sample Sparing Assays for Monitoring Immune Responses (U24 Clinical Trial Not Allowed) Apply for RFA AI 19 017 Funding Number: RFA AI 19 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pragmatic clinical trial on efficacy of managing reduced iron stores on risk of clinically important events in older adults with heart failure and anemia (U01 Clinical Trial Required) Apply for PA 19 230 Funding Number: PA 19 230 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) Apply for PAR 19 231 Funding Number: PAR 19 231 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) Apply for RFA RM 19 007 Funding Number: RFA RM 19 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) Apply for RFA RM 19 008 Funding Number: RFA RM 19 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Biomarker Discovery and Novel Point-of-Care Diagnostics for Active TB Disease Detection in HIV-1 Infected and Exposed Children (R01 Clinical Trial Optional) Apply for RFA AI 19 036 Funding Number: RFA AI 19 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clinical Trial Not Allowed) Apply for PAR 19 232 Funding Number: PAR 19 232 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Targeted Prevention for Tickborne Diseases (R01 Clinical Trial Not Allowed) Apply for RFA AI 19 037 Funding Number: RFA AI 19 037 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required) Apply for PAR 19 236 Funding Number: PAR 19 236 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFI 695 19 OVC 00001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.